181 related articles for article (PubMed ID: 38421203)
1. New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model.
Zhang W; Cheng W; Li J; Huang Z; Lin H; Zhang W
mSystems; 2024 Mar; 9(3):e0102723. PubMed ID: 38421203
[TBL] [Abstract][Full Text] [Related]
2. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
Lee JE; Lee SM; Jung J
Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills in regulating intestinal flora and improving non-alcoholic steatohepatitis].
Jian CF; Zhang BY; Wang CP; Sha YR; Li AR; Gong PY; Gu J; Tan R
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2038-2048. PubMed ID: 35531719
[TBL] [Abstract][Full Text] [Related]
4. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
5. [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].
Xia QY; Lu D; Zhang JM; Wei YC; Yang MM; Yang ZY; Cao MB
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1069-1076. PubMed ID: 34933425
[No Abstract] [Full Text] [Related]
6. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
[TBL] [Abstract][Full Text] [Related]
8. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial.
Hui D; Liu L; Azami NLB; Song J; Huang Y; Xu W; Wu C; Xie D; Jiang Y; Bian Y; Sun M
Front Endocrinol (Lausanne); 2022; 13():1107071. PubMed ID: 36743913
[TBL] [Abstract][Full Text] [Related]
9. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis].
Zou JJ; Li H; Zhou M; Huang QQ; Wu YJ; Yu R
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242
[TBL] [Abstract][Full Text] [Related]
10. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
Yun Y; Kim HN; Lee EJ; Ryu S; Chang Y; Shin H; Kim HL; Kim TH; Yoo K; Kim HY
PLoS One; 2019; 14(3):e0213692. PubMed ID: 30870486
[TBL] [Abstract][Full Text] [Related]
11. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
Lin YC; Lin HF; Wu CC; Chen CL; Ni YH
J Gastroenterol; 2022 Nov; 57(11):913-925. PubMed ID: 35976494
[TBL] [Abstract][Full Text] [Related]
13. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
[TBL] [Abstract][Full Text] [Related]
15. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
16. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
17. Effect of chin brick tea [Camellia sinensis (L.) Kuntze] on lipid metabolism and inflammation by modulating intestinal flora and bile acids in mice with non-alcoholic fatty liver disease.
Jin C; Zhou T; Duan Z; Deng Y; Zhang X; Xiao C; He J; He G; Zhou Y; Li S
J Ethnopharmacol; 2024 Jan; 318(Pt B):116950. PubMed ID: 37506781
[TBL] [Abstract][Full Text] [Related]
18. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice.
Xie F; Xu HF; Zhang J; Liu XN; Kou BX; Cai MY; Wu J; Dong JL; Meng QH; Wang Y; Chen D; Zhang Y
Front Immunol; 2022; 13():974872. PubMed ID: 36466835
[TBL] [Abstract][Full Text] [Related]
20. Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites.
Zhang B; Luo X; Han C; Liu J; Zhang L; Qi J; Gu J; Tan R; Gong P
J Ethnopharmacol; 2023 Apr; 305():116082. PubMed ID: 36581163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
